Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5467)
All Articles published online
|
Publishing Process of This Article
|
Aug 15, 2013 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pathophysiology
ISSN
2150-5330
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Giorgio F, Principi M, De Francesco V, Zullo A, Losurdo G, Di Leo A, Ierardi E. Primary clarithromycin resistance to |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v4/i3/43.htm |
| Number | Citing Articles |
| 1 |
Karolina Klesiewicz, Elżbieta Karczewska, Paweł Nowak, Iwona Skiba-Kurek, Edward Sito, Katarzyna Pańczyk, Paulina Koczurkiewicz, Dorota Żelaszczyk, Elżbieta Pękala, Anna M. Waszkielewicz, Alicja Budak, Henryk Marona, Agnieszka Gunia-Krzyżak. Anti-Helicobacter pylori activities of selected N-substituted cinnamamide derivatives evaluated on reference and clinical bacterial strains. The Journal of Antibiotics 2018; 71(5): 543 doi: 10.1038/s41429-018-0027-1
|
| 2 |
J. C. Delchier, P. Malfertheiner, R. Thieroff‐Ekerdt. Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori. Alimentary Pharmacology & Therapeutics 2014; 40(2): 171 doi: 10.1111/apt.12808
|
| 3 |
GHALIA KHODER, ASMA A. AL-MENHALI, FARAH AL-YASSIR, SHERIF M. KARAM. Potential role of probiotics in the management of gastric ulcer. Experimental and Therapeutic Medicine 2016; 12(1): 3 doi: 10.3892/etm.2016.3293
|
| 4 |
Hyasinta Jaka, Jee Ah. Rhee, Linda Östlundh, Luke Smart, Robert Peck, Andreas Mueller, Christa Kasang, Stephen E. Mshana. The magnitude of antibiotic resistance to Helicobacter pylori in Africa and identified mutations which confer resistance to antibiotics: systematic review and meta-analysis. BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3099-4
|
| 5 |
G. Losurdo, G. Leandro, M. Principi, F. Giorgio, L. Montenegro, C. Sorrentino, E. Ierardi, A. Di Leo. Sequential vs. prolonged 14-day triple therapy forHelicobacter pylorieradication: the meta-analysis may be influenced by ‘geographical weighting’. International Journal of Clinical Practice 2015; 69(10): 1112 doi: 10.1111/ijcp.12687
|
| 6 |
Mohammad Zamani, Shaghayegh Alizadeh-Tabari, Vahid Zamani, Javad Shokri-Shirvani, Mohammad H. Derakhshan. Worldwide and Regional Efficacy Estimates of First-line Helicobacter pylori Treatments. Journal of Clinical Gastroenterology 2022; 56(2): 114 doi: 10.1097/MCG.0000000000001641
|
| 7 |
Mohammad Zamani, Vahid Zamani, Mohammad H. Derakhshan, Javad Shokri-Shirvani. The efficacy of first-line regimens for Helicobacter pylori eradication in different continents. Medicine 2018; 97(50): e13682 doi: 10.1097/MD.0000000000013682
|
| 8 |
Yiqiao Xin, Jan Manson, Lindsay Govan, Robin Harbour, Jenny Bennison, Eleanor Watson, Olivia Wu. Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0491-7
|
| 9 |
Teresa Fasciana, Cinzia Calà, Celestino Bonura, Enza Di Carlo, Domenica Matranga, Giuseppe Scarpulla, Michele Manganaro, Salvatore Camilleri, Anna Giammanco. Resistance to clarithromycin and genotypes in Helicobacter pylori strains isolated in Sicily.
Journal of Medical Microbiology
2015; 64(11): 1408 doi: 10.1099/jmm.0.000163
|
| 10 |
Yue-Feng Tong, Jun Lv, Li-Yuan Ying, Fang Xu, Bo Qin, Ming-Tong Chen, Fei Meng, Miao-Ying Tu, Ning-Min Yang, You-Ming Li, Jian-Zhong Zhang. Seven-day triple therapy is a better choice for <italic>Helicobacter pylori</italic> eradication in regions with low antibiotic resistance. World Journal of Gastroenterology 2015; 21(46): 13073-13079 doi: 10.3748/wjg.v21.i46.13073
|
| 11 |
Lassaad Chtourou, Manel Moalla, Basma Mnif, Hend Smaoui, Hela Gdoura, Mona Boudabous, Leila Mnif, Ali Amouri, Adnene Hammami, Nabil Tahri. Prevalence of Helicobacter pylori resistance to clarithromycin in Tunisia.
Journal of Medical Microbiology
2022; 71(8) doi: 10.1099/jmm.0.001561
|
| 12 |
NL Ubhayawardana, MM Weerasekera, D Weerasekera, K Samarasinghe, CP Gunasekera, N Fernando. Detection of clarithromycin-resistant Helicobacter pylori strains in a dyspeptic patient population in Sri Lanka by polymerase chain reaction-restriction fragment length polymorphism. Indian Journal of Medical Microbiology 2015; 33(3): 374 doi: 10.4103/0255-0857.158557
|
| 13 |
Hiroshi Kishikawa, Kayoko Kimura, Sakiko Takarabe, Shogo Kaida, Jiro Nishida. Helicobacter pyloriAntibody Titer and Gastric Cancer Screening. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/156719
|
| 14 |
Han Chen, Yini Dang, Xiaoying Zhou, Bingtuan Liu, Shiyu Liu, Guoxin Zhang. Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication. Medicine 2016; 95(7): e2750 doi: 10.1097/MD.0000000000002750
|
| 15 |
Hyasinta Jaka, Nele Rüttgerodt, Wolfgang Bohne, Andreas Mueller, Uwe Gross, Christa Kasang, Stephen E. Mshana. Helicobacter pyloriMutations Conferring Resistance to Fluoroquinolones and Clarithromycin among Dyspeptic Patients Attending a Tertiary Hospital, Tanzania. Canadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/8481375
|
| 16 |
Seong Hyun Cho, Moon Sik Park, Seon-Young Park, Dong Hyun Kim, Hye-Su You, Hyun-Soo Kim. Effectiveness of 7-day triple therapy with half-dose clarithromycin for the eradication of Helicobacter pylori without the A2143G and A2142G point mutations of the 23S rRNA gene in a high clarithromycin resistance area. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1150396
|
| 17 |
Min-Min Zhang, Wei Qian, Ying-Yi Qin, Jia He, Yu-Hao Zhou. Probiotics in <italic>Helicobacter pylori</italic> eradication therapy: A systematic review and meta-analysis. World Journal of Gastroenterology 2015; 21(14): 4345-4357 doi: 10.3748/wjg.v21.i14.4345
|
| 18 |
Carolina A. Serrano, Miguel A. Leon, Camila Palma, Macarena Vera, Caroll Hernandez, Paul R. Harris. Helicobacter pylori‐Clarithromycin Resistance in Symptomatic Pediatric Patients in a High Prevalence Country. Journal of Pediatric Gastroenterology and Nutrition 2017; 64(3) doi: 10.1097/MPG.0000000000001257
|
| 19 |
Cheng-Yen Kao, Ai-Yun Lee, Ay-Huey Huang, Pin-Yi Song, Yao-Jong Yang, Shew-Meei Sheu, Wei-Lun Chang, Bor-Shyang Sheu, Jiunn-Jong Wu. Heteroresistance of Helicobacter pylori from the same patient prior to antibiotic treatment. Infection, Genetics and Evolution 2014; 23: 196 doi: 10.1016/j.meegid.2014.02.009
|
| 20 |
Rodrigo Buzinaro Suzuki, Rodrigo Augusto Basso Lopes, George Arouche da Câmara Lopes, Tin Hung Ho, Márcia Aparecida Sperança. Low Helicobacter pylori primary resistance to clarithromycin in gastric biopsy specimens from dyspeptic patients of a city in the interior of São Paulo, Brazil. BMC Gastroenterology 2013; 13(1) doi: 10.1186/1471-230X-13-164
|
| 21 |
Benjamin D. Gold. Resistance Testing for Helicobacter pylori Infection. Journal of Pediatric Gastroenterology and Nutrition 2014; 59(1): 3 doi: 10.1097/MPG.0000000000000438
|
| 22 |
Nuno Almeida, Maria Manuel Donato, José Manuel Romãozinho, Cristina Luxo, Olga Cardoso, Maria Augusta Cipriano, Carol Marinho, Alexandra Fernandes, Carlos Calhau, Carlos Sofia. Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0245-y
|
| 23 |
Amin Talebi Bezmin Abadi. Helicobacter pylori treatment: New perspectives using current experience. Journal of Global Antimicrobial Resistance 2017; 8: 123 doi: 10.1016/j.jgar.2016.11.008
|
| 24 |
Barbara Iwańczak, Ruggiero Francavailla. Helicobacter pylori Infection in Pediatrics. Helicobacter 2014; 19(s1): 46 doi: 10.1111/hel.12158
|
| 25 |
Reza Khashei, Mahintaj Dara, Abdollah Bazargani, Kamran Bagheri Lankarani, Alireza Taghavi, Maryam Moeini, Behzad Dehghani, Maryam Sohrabi. High rate of A2142G point mutation associated with clarithromycin resistance among Iranian Helicobacter pylori clinical isolates. APMIS 2016; 124(9): 787 doi: 10.1111/apm.12567
|
| 26 |
Camelia Quek, Son T. Pham, Kieu T. Tran, Binh T. Pham, Loc V. Huynh, Ngan B.L. Luu, Thao K.T. Le, Kelly Quek, Van H. Pham. Antimicrobial susceptibility and clarithromycin resistance patterns of Helicobacter pylori clinical isolates in Vietnam. F1000Research 2016; 5: 671 doi: 10.12688/f1000research.8239.1
|
| 27 |
Natalie Clines, Erin Beckman, Iddya Karunasagar. Development of a high throughput human stool specimen processing method for a molecular Helicobacter pylori clarithromycin resistance assay. PLOS ONE 2019; 14(12): e0224356 doi: 10.1371/journal.pone.0224356
|